etidronate has been researched along with Osteitis Deformans in 254 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Osteitis Deformans: A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nineteen patients with Paget's disease and four patients with hypercalcemia of malignancy underwent hypocalcemic therapy with etidronate disodium (etidronate) administered intravenously." | 7.67 | Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry. ( Arlot, M; Chapuy, MC; Charhon, S; Delmas, P; Edouard, C; Meunier, PJ, 1987) |
| "Although etidronate is effective, risedronate offers a shorter duration of therapy, better and longer-lasting remission, significant reductions in pain, and provides additional remission in subjects who exhibited an incomplete response to previous etidronate treatment." | 5.09 | A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group. ( Axelrod, DW; Bekker, PJ; Brown, JP; Hoseyni, MS; Miller, PD; Siris, ES, 1999) |
| " Other end points included changes in urinary deoxypyridinoline excretion, pain, functional impairment scores, and radiological osteolysis." | 5.08 | Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. ( Altman, R; Conte, JM; Favus, M; Lombardi, A; Lyles, K; McIlwain, H; Murphy, WA; Reda, C; Rude, R; Seton, M; Siris, E; Thompson, D; Tiegs, R; Tucci, JR; Weinstein, RS; Yates, AJ; Zimering, M, 1996) |
| "Studies of risedronate were obtained from the MEDLINE database (1966 to the present) of references using risedronate, risedronic acid, osteoporosis, and human subject as keywords." | 4.81 | Risedronate: a clinical review. ( Crandall, C, 2001) |
| " The surgical approach was rejected, but the severity of symptoms and osteitis deformans biochemical activity needed a treatment; it was orientated to modify bone turnover using etidronate, a bisphosphonate, which induced clinical improvement and a decrease in serum alkaline phosphatase as well as in other bone resorption markers, without side effects." | 4.79 | [Paget's disease of bone and basilar impression associated with an Arnold-Chiari type-1 malformation]. ( de Portugal Alvarez, J; Gómez Sánchez, JC; Iglesias-Osma, C; Querol Prieto, R; Suquia Múgica, B, 1997) |
| "Control of Paget's disease of bone has been possible through treatment with agents that decrease bone resorption; calcitonins, diphosphonates, and mithramycin." | 3.75 | Etidronate disodium in the treatment of Paget's disease of bone. ( Krane, SM, 1982) |
| "Inhibition of skeletal mineralisation is a well-recognized complication of disodium etidronate therapy that was identified in the earliest studies of its use in osteoporosis and Paget's disease." | 3.70 | Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease. ( MacGowan, JR; Morris, VH; Pringle, J; Stamp, TC, 2000) |
| "Transiliac bone biopsies carried out on 13 patients with Paget's disease to evaluate the effects of low-dose diphosphonate (disodium etidronate) therapy showed focal osteomalacia in the 9 patients in whom post-therapy specimens were taken through pagetic bone." | 3.67 | Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease. ( Boyce, BF; Boyle, IT; Fogelman, I; Johnston, E; Ralston, S; Smith, L, 1984) |
| "Nineteen patients with Paget's disease and four patients with hypercalcemia of malignancy underwent hypocalcemic therapy with etidronate disodium (etidronate) administered intravenously." | 3.67 | Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry. ( Arlot, M; Chapuy, MC; Charhon, S; Delmas, P; Edouard, C; Meunier, PJ, 1987) |
| "13 patients with polyosseous Paget's disease were treated for a mean period of 7 months with disodium etidronate (EHDP, ethylidene-1-hydroxy-1,1-diphosphonate); the average daily dosage was 5 mg/kg body weight." | 3.67 | [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease]. ( Frühwald, F; Kolbe, H; Kovarik, J; Niebauer, B; Woloszczuk, W, 1985) |
| "Localised foot pain occurred in four patients with Paget's disease of bone or myositis ossificans who were treated with disodium etidronate (EHDP) in a dose of 10 to 20 mg/kg body weight/day for four to six months." | 3.66 | Diphosphonates and painful feet. ( Evans, RA; MacDonald, D, 1983) |
| " Two groups of patients with either low (osteoporosis), (n = 15) or high (Paget's disease, n = 6) bone turnover were studied before and after sodium fluoride (NaF) and diphosphonate (EHDP) treatment, respectively." | 3.65 | Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease. ( Dambacher, MA; Guncaga, J; Haas, HG; Lauffenburger, T; Lentner, C; Olah, AJ, 1977) |
| "5 mg once daily was well tolerated by patients with PDB, even though the dosage was seven times higher than that approved for the treatment of osteoporosis in Japan (2." | 2.75 | Efficacy, tolerability, and safety of risedronate in Japanese patients with Paget's disease of bone. ( Hashimoto, J; Takata, S; Yoh, K; Yoshimura, N, 2010) |
| "Zoledronic acid (ZOL) is a potent bisphosphonate that produces a rapid and complete control of the increased bone turnover of Paget's disease." | 2.73 | Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate. ( Brown, JP; Curiel, MD; Devogelaer, JP; Eriksen, EF; Fashola, T; Fraser, WD; Hooper, M; Hosking, D; Lyles, K; Miller, P; Pak, J; Reid, IR; Saidi, Y; Su, G; Zelenakas, K, 2007) |
| "Zoledronic acid was associated with a shorter median time to a first therapeutic response (64 vs." | 2.71 | Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. ( Brown, JP; Fraser, W; Hosking, D; Luchi, M; Lyles, K; Mesenbrink, P; Miller, P; Pak, J; Reid, IR; Richardson, P; Saidi, Y; Su, G; Zelenakas, K, 2005) |
| " The data show that there is a dose-response with risedronate: patients who received 30 mg oral risedronate for 28 days benefited most, with a mean percentage decrease in AP excess of 72." | 2.69 | Risedronate, a highly effective, short-term oral treatment for Paget's disease: a dose-response study. ( Bekker, PJ; Brown, JP; Hosking, DJ; Johnson, TD; Johnston, CC; Reginster, J; Ryan, WG; Ste-Marie, L, 1999) |
| "To compare the efficacy and safety of tiludronate and etidronate at the same dosage (400 mg/day) for the treatment of active Paget's disease of bone." | 2.68 | Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone. ( Devogelaer, JP; Dougados, M; Farrerons, J; Gennari, C; Kruse, HP; Mulder, H; Picot, C; Reginster, JY; Roux, C; Titeux, L, 1995) |
| "Paget's disease of bone is characterized by a high bone turnover." | 2.68 | Biological and radiological responses to oral etidronate and tiludronate in Paget's disease of bone. ( Devogelaer, JP; Malghem, J; Nagant de Deuxchaisnes, C; Stasse, P, 1997) |
| "Paget's disease of bone is characterized by primary osteoclastic dysfunction and prolonged treatment with conventional medications including calcitonin and etidronate, results in a number of patients becoming refractory to treatment." | 2.67 | Pamidronate is effective for Paget's disease of bone refractory to conventional therapy. ( Gunasekera, RD; Wimalawansa, SJ, 1993) |
| "When etidronate was given by mouth there was a progressive decrease in fasting urinary calcium excretion and a rise in serum 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3]." | 2.66 | Contrasting effects of intravenous and oral etidronate on vitamin D metabolism in man. ( Guilland-Cumming, DF; Kanis, JA; Lawson-Matthew, PJ; Russell, RG; Yates, AJ, 1988) |
| " Six BPs are currently approved by the US Food and Drug Administration (FDA) for the treatment of Paget disease, and each has unique characteristics, such as response rates and requirements for dosage and administration, relevant to clinical outcome." | 2.44 | Paget disease of bone: therapeutic options. ( Silverman, SL, 2008) |
| " Bisphosphonates restore normal bone turnover and relieve bone pain, but oral formulations may be limited by complicated dosing regimens and poor gastrointestinal absorption." | 2.44 | A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. ( Abelson, A, 2008) |
| " Mineralisation defects in forming bone may be avoided by the use of an initial dosage of 5 mg/kg/day for up to 6 months; dosages above 10 mg/kg/day should be limited to 3 months' duration, and dosages greater than 20 mg/kg/day should be avoided." | 2.39 | Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. ( Dunn, CJ; Fitton, A; Sorkin, EM, 1994) |
| "The ideal treatment for Paget's disease of bone should control turnover irrespective of its initial activity and produce a sustained remission once treatment is withdrawn." | 2.36 | Calcitonin and diphosphonate in the treatment of Paget's disease of bone. ( Hosking, DJ, 1981) |
| "Etidronate is a non-nitrogen-containing bisphosphonate." | 1.56 | History of etidronate. ( Chesnut, CH; Genant, HK; Harris, ST; Jackson, RD; Licata, AA; Miller, PD; Mysiw, WJ; Richmond, B; Valent, D; Watts, NB, 2020) |
| "Paget disease of bone is the most common metabolic bone disease after osteoporosis, affecting 2-4% of adults over 55 years of age." | 1.38 | Paget disease of bone - an update. ( Britton, C; Walsh, J, 2012) |
| "Pamidronate treatment (60 mg/day for 3 days) was repeated in patients without evidence of PDB remission at day 120." | 1.32 | Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates. ( Mossetti, G; Nunziata, V; Rendina, D; Sorrentino, M; Viceconti, R, 2004) |
| "Etidronate treatment at 200 mg/day resulted in the improvement of bone metabolism markers and bone scintigraphy findings." | 1.32 | Two cases of monostotic Paget's disease: effects of bisphosphonate. ( Aoki, N; Harada, T; Hoshiro, M; Iwai, H; Miyatake, T; Nishimura, A; Ohno, Y, 2003) |
| "Treatment with etidronate disodium resulted in a temporary 40% reduction in serum alkaline phosphatase and 24 h urine hydroxyproline excretion, with reduction in serum osteocalcin from two times the upper limit of normal to a subnormal level." | 1.29 | Hereditary hyperphosphatasia: 20 year follow-up and response to disodium etidronate. ( Dempster, D; Lindsay, R; Parisien, M; Shane, E; Singer, F; Siris, E, 1994) |
| "Paget's disease of bone is a localized progressive disease, characterized by increased bone remodeling, bone hypertrophy, and abnormal bone structure, leading to pain and deformity." | 1.29 | Therapeutic strategy in Paget's disease of bone. ( Meunier, PJ; Vignot, E, 1995) |
| "Paget's disease of bone is most commonly seen in the spine; it may either be asymptomatic or may cause pain and neurologic impairment." | 1.28 | Clinical and radiographic improvement of bone of the second lumbar vertebra in Paget's disease following therapy with etidronate disodium: a case report. ( Cooperstein, L; Goodman, M; Helfrich, DJ; Nicholas, JJ, 1989) |
| "Paget's disease of bone is a process of increased bone remodeling resulting in architecturally abnormal bone that may affect any area of the skeleton." | 1.27 | Current concepts of Paget's disease of bone. ( Lane, JM; Merkow, RL, 1984) |
| "Paget's disease of bone in 51 patients was treated with ethane-1, hydroxy-1,1 diphosphonate (EHDP) for six months at a dosage of 5 mg/kg/day." | 1.27 | Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day). ( Alexandre, CM; Chapuy, MC; Edouard, C; Johnston, CC; Meunier, PJ; Vignon, E, 1983) |
| "Osteomalacia is caused by inadequate or delayed mineralization of bone and is treated by correcting the abnormal intake, loss, or metabolism of vitamin D, phosphate, and calcium." | 1.27 | Osteoporosis, osteomalacia, rickets, and Paget's disease. ( Gall, EP; Nugent, CA; Pitt, MJ, 1984) |
| "Paget's disease of bone is a slowly progressive and frequently disabling disorder of unknown cause." | 1.27 | Pathophysiology and modern management of Paget's disease. ( Ryan, WG, 1983) |
| " Combinations of calcitonin and disodium etidronate in conventional dosage seem to result in an additive suppressant effect on bone turnover and may be indicated for more active disease." | 1.27 | Paget's disease of bone. An update on management. ( Hosking, DJ, 1985) |
| " It is conjectural whether this was related to the chronic use of a diphosphonate in therapy." | 1.27 | Unusual scintigraphic findings in a case of treated monostotic Paget's disease. ( Slavin, JD; Spencer, RP; Ziewacz, JT, 1988) |
| " Group A was treated with calcitonin and calcium, at the dosage indicated above, for 10 days a month during 6 months." | 1.27 | Biochemical assessment of acute and chronic treatment of Paget's bone disease with calcitonin and calcium with and without biphosphonate. ( Espinós, D; Hernández, D; Hernández, ER; Rico, H; Younes, M, 1988) |
| " The medication is generally well tolerated and at the recommended dosage there is no evidence of increased fracture rate." | 1.26 | Use of etidronate (EHDP) in Paget's disease of bone. ( Johnston, CC; Khairi, MR; Meunier, PJ, 1980) |
| " reduced the scanning hyperfixation of the active pagetic areas in 6 patients: it likewise more or less markedly reduced hyperosteoclastosis, with no apparent increase in the osteoid volume; two patients suffering from upper maxillary disease regressed clinically (dentures had become too large); headache and hypacusia were not modified; the response to the treatment seems to depend on three factors: the activity of the patient, the dosage used, and an individual factor which may be linked to the severity of the osteoidosis." | 1.26 | [Treatment of Paget's disease with 1-ethane-1-hydroxy-1-diphosphonate]. ( Basle, M; Bontoux, L; Bontoux-Carre, E; Jallet, P; Moreau, R; Renier, JC, 1982) |
| "1." | 1.26 | Serum proline imino-peptidase activity in normal adult subjects and in patients with Paget's disease of bone. ( Francis, MJ; Smith, R; Walton, RJ; Whiteley, J, 1976) |
| "Etidronate has been more efficient in reducing biological parameters, whereas calcitonin has produced a faster symptomatic response." | 1.26 | [Treatment of Paget's disease of bone: diphosphonates or calcitonin?]. ( Courvoisier, B; Davoine, GA; Jung, A, 1981) |
| "Six patients with Paget disease of bone were treated with a 6-mo course of disodium-ethane-1-hydroxy-1, 1-diphosphate (EHDP) at a dosage of 5 mg/kg/day (one patient) or 20 mg/kg/day (five patients)." | 1.26 | An apparent 1,25-dihydroxyvitamin D-independent stimulation of intestinal calcium absorption in patients with Paget disease of bone during a short-term diphosphonate therapy. ( Norman, DA; Pak, CY; Zerwekh, JE, 1981) |
| "Obstructive hydrocephalus may result." | 1.26 | Paget's disease and the nervous system. ( Culebras, A; Feldman, RG; Schmidek, HH, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 170 (66.93) | 18.7374 |
| 1990's | 39 (15.35) | 18.2507 |
| 2000's | 39 (15.35) | 29.6817 |
| 2010's | 5 (1.97) | 24.3611 |
| 2020's | 1 (0.39) | 2.80 |
| Authors | Studies |
|---|---|
| Watts, NB | 1 |
| Chesnut, CH | 1 |
| Genant, HK | 1 |
| Harris, ST | 1 |
| Jackson, RD | 1 |
| Licata, AA | 1 |
| Miller, PD | 4 |
| Mysiw, WJ | 1 |
| Richmond, B | 1 |
| Valent, D | 1 |
| Silverman, SL | 1 |
| Torres, J | 1 |
| Tamimi, F | 1 |
| Garcia, I | 1 |
| Herrero, A | 1 |
| Rivera, B | 1 |
| Sobrino, JA | 1 |
| Hernández, G | 1 |
| Pirih, FQ | 1 |
| Zablotsky, M | 1 |
| Cordell, K | 1 |
| McCauley, LK | 1 |
| Yoh, K | 1 |
| Takata, S | 3 |
| Yoshimura, N | 1 |
| Hashimoto, J | 1 |
| Woo, JH | 1 |
| Kim, S | 1 |
| Choi, SJ | 1 |
| Lee, YH | 1 |
| Ji, JD | 1 |
| Song, GG | 1 |
| Britton, C | 1 |
| Walsh, J | 1 |
| Hoppé, E | 1 |
| Masson, C | 1 |
| Laffitte, A | 1 |
| Chappard, D | 1 |
| Audran, M | 3 |
| Nishida, Y | 1 |
| Yamada, Y | 1 |
| Tsukushi, S | 1 |
| Sugiura, H | 1 |
| Urakawa, H | 1 |
| Ishiguro, N | 1 |
| Fournier, P | 1 |
| Boissier, S | 1 |
| Filleur, S | 1 |
| Guglielmi, J | 1 |
| Cabon, F | 1 |
| Colombel, M | 1 |
| Clézardin, P | 1 |
| Hoshiro, M | 1 |
| Harada, T | 1 |
| Iwai, H | 1 |
| Miyatake, T | 1 |
| Nishimura, A | 1 |
| Ohno, Y | 1 |
| Aoki, N | 1 |
| Takada, J | 1 |
| Iba, K | 1 |
| Yamashita, T | 1 |
| Ishii, S | 1 |
| Rendina, D | 3 |
| Mossetti, G | 3 |
| Viceconti, R | 2 |
| Sorrentino, M | 1 |
| Nunziata, V | 2 |
| Lee, CH | 1 |
| Han, SH | 1 |
| Yoon, BY | 1 |
| Lee, YW | 1 |
| De Filippo, G | 2 |
| Di Domenico, G | 1 |
| Cioffi, M | 1 |
| Postiglione, L | 1 |
| Brixen, KT | 1 |
| Abrahamsen, B | 1 |
| Kassem, MS | 1 |
| Mosekilde, L | 1 |
| Orcel, P | 1 |
| Rousière, M | 1 |
| Barrera, BA | 1 |
| Wilton, L | 1 |
| Harris, S | 3 |
| Shakir, SA | 1 |
| Reid, IR | 2 |
| Miller, P | 2 |
| Lyles, K | 3 |
| Fraser, W | 1 |
| Brown, JP | 8 |
| Saidi, Y | 2 |
| Mesenbrink, P | 1 |
| Su, G | 2 |
| Pak, J | 2 |
| Zelenakas, K | 2 |
| Luchi, M | 1 |
| Richardson, P | 1 |
| Hosking, D | 3 |
| Liel, Y | 1 |
| Füessl, HS | 1 |
| Whitson, HE | 1 |
| Lobaugh, B | 1 |
| Lyles, KW | 1 |
| Krane, SM | 4 |
| Fraser, WD | 1 |
| Curiel, MD | 1 |
| Devogelaer, JP | 5 |
| Hooper, M | 1 |
| Fashola, T | 1 |
| Eriksen, EF | 1 |
| Zillikens, MC | 1 |
| Ginai, AZ | 1 |
| Pols, HA | 1 |
| Labinson, P | 1 |
| Taxel, P | 1 |
| Saura, R | 1 |
| Abelson, A | 1 |
| Olmos Martínez, JM | 1 |
| Hernández Hernández, JL | 1 |
| Martínez García, J | 1 |
| González Macías, J | 1 |
| Boyce, BF | 3 |
| Smith, L | 1 |
| Fogelman, I | 6 |
| Johnston, E | 1 |
| Ralston, S | 2 |
| Boyle, IT | 5 |
| Ryan, WG | 6 |
| Schwartz, TB | 1 |
| Kanis, JA | 12 |
| Evanson, JM | 1 |
| Russell, RG | 11 |
| Ringe, JD | 1 |
| Boudreau, RJ | 1 |
| Lisbona, R | 1 |
| Hadjipavlou, A | 1 |
| Siris, ES | 7 |
| Nugent, CA | 1 |
| Gall, EP | 1 |
| Pitt, MJ | 1 |
| Ziegler, R | 5 |
| Baldauf, G | 1 |
| de La Rochefoucauld, B | 1 |
| Basset, JY | 1 |
| Rondier, J | 2 |
| Cayla, J | 2 |
| Ancri, D | 1 |
| Fleisch, H | 3 |
| Shalev, O | 1 |
| Menczel, J | 2 |
| Gay, JD | 1 |
| Poznanski, WJ | 1 |
| Alexandre, CM | 1 |
| Chapuy, MC | 7 |
| Vignon, E | 3 |
| Edouard, C | 7 |
| Johnston, CC | 11 |
| Meunier, PJ | 10 |
| Evans, RA | 4 |
| Eisinger, J | 2 |
| Schiano, A | 1 |
| d'Omezon, Y | 1 |
| Ouaniche, J | 2 |
| MacDonald, D | 1 |
| Schnur, W | 1 |
| Dunstan, CR | 1 |
| Hills, E | 1 |
| Wong, SY | 1 |
| Holz, G | 1 |
| Delling, G | 1 |
| Huchet, B | 1 |
| Basle, MF | 3 |
| Rebel, A | 1 |
| Renier, JC | 3 |
| Filmon, R | 1 |
| Malkani, K | 1 |
| Perry, HM | 2 |
| Droke, DM | 1 |
| Avioli, LV | 3 |
| Mautalen, CA | 2 |
| Jaspers, MM | 1 |
| Pauwels, EK | 3 |
| Harinck, HI | 2 |
| Blom, J | 1 |
| Smith, ML | 2 |
| Merkow, RL | 2 |
| Lane, JM | 2 |
| Fraser, TR | 3 |
| Ibbertson, HK | 3 |
| Holdaway, IM | 2 |
| Rutland, M | 1 |
| King, A | 1 |
| Dodd, G | 1 |
| Wattie, DJ | 2 |
| Raisz, LG | 1 |
| Bijvoet, OL | 10 |
| Frijlink, WB | 2 |
| Jie, K | 1 |
| van der Linden, H | 1 |
| Meijer, CJ | 1 |
| Mulder, H | 2 |
| van Paassen, HC | 1 |
| Reitsma, PH | 1 |
| te Velde, J | 1 |
| de Vries, E | 1 |
| van der Wey, JP | 1 |
| Lee, JY | 1 |
| Arlot, ME | 1 |
| Frame, B | 1 |
| Marel, GM | 1 |
| Douglas, DL | 2 |
| Duckworth, T | 1 |
| Jefferson, AA | 1 |
| Martin, TJ | 1 |
| Wallach, S | 2 |
| Khairi, MR | 6 |
| Canfield, RE | 2 |
| Jacobs, TP | 3 |
| Baquiran, DC | 1 |
| Alexandre, C | 5 |
| Bressot, C | 1 |
| Arlot, M | 2 |
| Mathieu, L | 2 |
| Norman, DA | 1 |
| Zerwekh, JE | 1 |
| Pak, CY | 1 |
| Bessent, RG | 1 |
| Gordon, D | 1 |
| Davoine, GA | 1 |
| Jung, A | 2 |
| Courvoisier, B | 2 |
| Hosking, DJ | 14 |
| Mallette, LE | 2 |
| Nagant de Deuxchaisnes, C | 3 |
| Rombouts-Lindemans, C | 1 |
| Huaux, JP | 2 |
| Malghem, J | 3 |
| Maldague, B | 2 |
| Withofs, H | 1 |
| Meersseman, F | 1 |
| Jaeger, P | 1 |
| Bischoff-Delaloye, A | 1 |
| Burckhardt, P | 1 |
| Nuti, R | 1 |
| Turchetti, V | 1 |
| Righi, G | 1 |
| Vattimo, A | 2 |
| Bontoux-Carre, E | 1 |
| Bontoux, L | 1 |
| Basle, M | 1 |
| Moreau, R | 1 |
| Jallet, P | 1 |
| McKillop, JH | 3 |
| Ghiringhelli, G | 1 |
| Fogel, M | 1 |
| Varela de Rodríguez, J | 1 |
| Casco, C | 1 |
| Mautelén, C | 1 |
| Nusimovich, B | 1 |
| Vellenga, CJ | 2 |
| Stoddart, KE | 1 |
| Spector, PJ | 1 |
| Khairi, RA | 1 |
| Blumsohn, A | 1 |
| Naylor, KE | 1 |
| Assiri, AM | 1 |
| Eastell, R | 1 |
| Mazières, B | 1 |
| Rutland, MD | 1 |
| Haddad, JG | 1 |
| Roux, C | 1 |
| Gennari, C | 2 |
| Farrerons, J | 1 |
| Kruse, HP | 1 |
| Picot, C | 1 |
| Titeux, L | 1 |
| Reginster, JY | 4 |
| Dougados, M | 1 |
| Rapado, A | 1 |
| López Gavilanes, E | 1 |
| Palomino, P | 1 |
| Yagüe, M | 1 |
| de la Piedra, C | 1 |
| Díaz Curiel, M | 1 |
| Ortiz, F | 1 |
| Hamdy, RC | 1 |
| Dunn, CJ | 2 |
| Fitton, A | 1 |
| Sorkin, EM | 1 |
| Kylstra, JW | 1 |
| Bekker, PJ | 5 |
| Axelrod, DW | 2 |
| Altman, RD | 8 |
| Singer, FR | 5 |
| De Smet, L | 1 |
| Roosen, P | 1 |
| Zachee, B | 1 |
| Fabry, G | 1 |
| Singer, F | 1 |
| Siris, E | 2 |
| Shane, E | 1 |
| Dempster, D | 1 |
| Lindsay, R | 1 |
| Parisien, M | 1 |
| Wimalawansa, SJ | 1 |
| Gunasekera, RD | 1 |
| Vignot, E | 1 |
| Weinstein, RS | 1 |
| Altman, R | 1 |
| Conte, JM | 1 |
| Favus, M | 1 |
| Lombardi, A | 2 |
| McIlwain, H | 1 |
| Murphy, WA | 1 |
| Reda, C | 1 |
| Rude, R | 1 |
| Seton, M | 1 |
| Tiegs, R | 1 |
| Thompson, D | 1 |
| Tucci, JR | 2 |
| Yates, AJ | 6 |
| Zimering, M | 1 |
| Marin, F | 1 |
| Billey, T | 1 |
| Lassoued, S | 2 |
| Stasse, P | 1 |
| Iglesias-Osma, C | 1 |
| Gómez Sánchez, JC | 1 |
| Suquia Múgica, B | 1 |
| Querol Prieto, R | 1 |
| de Portugal Alvarez, J | 1 |
| Eusebio, RA | 4 |
| Chines, AA | 3 |
| Patel, S | 1 |
| Pearson, D | 1 |
| Bhallah, A | 1 |
| Maslanka, W | 1 |
| White, DA | 1 |
| Zander, DR | 1 |
| Lander, P | 1 |
| Bégin, LR | 1 |
| Hadjipavlou, AG | 2 |
| Clemens, TL | 1 |
| Lang, R | 1 |
| McClung, MR | 1 |
| Ste-Marie, L | 1 |
| Reginster, J | 1 |
| Johnson, TD | 1 |
| Koga, K | 1 |
| Kawasaki, K | 1 |
| Kohno, S | 1 |
| Yamada, K | 1 |
| Itoh, T | 1 |
| Nonaka, K | 1 |
| Hoseyni, MS | 1 |
| Hussar, DA | 1 |
| Myers, WR | 1 |
| Ritter-Hrncirik, C | 1 |
| Hayes, CW | 1 |
| Rodionova, SS | 1 |
| Kolondaev, AF | 1 |
| Matkovskaia, TA | 1 |
| MacGowan, JR | 1 |
| Pringle, J | 1 |
| Morris, VH | 1 |
| Stamp, TC | 1 |
| Crandall, C | 1 |
| Drake, WM | 1 |
| Kendler, DL | 1 |
| Goa, KL | 1 |
| Chapurlat, RD | 1 |
| Delmas, PD | 2 |
| Pande, I | 1 |
| Umland, EM | 1 |
| Boyce, EG | 1 |
| Bannwarth, B | 1 |
| Shiraki, M | 1 |
| Fromm, G | 1 |
| Schajowicz, F | 2 |
| van Aken, J | 2 |
| Will, EJ | 2 |
| Posner, AS | 1 |
| Meunier, P | 4 |
| Ryckewaert, A | 1 |
| Lemaire, V | 1 |
| Tubiana, M | 1 |
| Hsu, TH | 1 |
| Hagen, R | 1 |
| Bjerkholt, H | 1 |
| Scott, DJ | 1 |
| Cullen, JC | 1 |
| Henley, JW | 1 |
| Stephens, ES | 1 |
| Tait, B | 1 |
| Trillet, M | 1 |
| Fischer, C | 1 |
| Walton, RJ | 3 |
| Smith, R | 6 |
| Feldman, RG | 1 |
| Culebras, A | 1 |
| Schmidek, HH | 1 |
| Canfield, R | 1 |
| Rosner, W | 1 |
| Skinner, J | 1 |
| McWhorter, J | 1 |
| Resnick, L | 1 |
| Feldman, F | 1 |
| Kammerman, S | 3 |
| Ryan, K | 1 |
| Kunigonis, M | 1 |
| Bohne, W | 1 |
| Kantrowitz, FG | 1 |
| Byrne, M | 1 |
| Pinnell, SR | 1 |
| Lauffenburger, T | 1 |
| Olah, AJ | 1 |
| Dambacher, MA | 1 |
| Guncaga, J | 1 |
| Lentner, C | 1 |
| Haas, HG | 1 |
| Greig, WR | 1 |
| Courpron, P | 2 |
| Bernard, J | 2 |
| DeRosa, GP | 2 |
| Wellman, HN | 2 |
| Schauwecker, D | 1 |
| Robb, JA | 1 |
| Rashid, M | 1 |
| Khairi, A | 1 |
| Johnston, C | 1 |
| Zimmermann, J | 1 |
| Schenk, RK | 1 |
| de Vries, HR | 2 |
| Froeling, PG | 1 |
| Goldman, AB | 1 |
| Braunstein, P | 1 |
| Wilkinson, D | 1 |
| Caniggia, A | 1 |
| Guideri, R | 1 |
| Nardi, P | 1 |
| Taubman, MB | 1 |
| Goldberg, B | 1 |
| Whiteley, J | 1 |
| Francis, MJ | 1 |
| Bohne, WH | 1 |
| Mermillod, B | 1 |
| Schenk, R | 1 |
| Burkhardt, P | 1 |
| Epiney, J | 1 |
| Morales Piga, A | 2 |
| Corres González, J | 1 |
| Pérez Ruiz, F | 1 |
| Horowitz, E | 1 |
| Miller, JL | 1 |
| Rose, LI | 1 |
| Devlin, RD | 1 |
| Gutteridge, DH | 1 |
| Prince, RL | 1 |
| Retallack, RW | 1 |
| Worth, GK | 1 |
| Patel, U | 1 |
| Gallacher, SJ | 1 |
| Costa, L | 1 |
| Servodio Iammarrone, C | 1 |
| Gigliotti, S | 1 |
| Giuzio, E | 1 |
| Buccafusca, G | 1 |
| Bickerstaff, DR | 1 |
| Burke, PH | 1 |
| O'Doherty, DP | 1 |
| Preston, CJ | 3 |
| Beard, DJ | 1 |
| Beneton, M | 2 |
| Ravault, A | 1 |
| Miravet, L | 1 |
| Kuntz, D | 1 |
| Foldes, J | 1 |
| Shamir, S | 1 |
| Kidroni, G | 1 |
| Fournié, A | 1 |
| Fournié, B | 1 |
| Nicholas, JJ | 1 |
| Helfrich, DJ | 1 |
| Cooperstein, L | 1 |
| Goodman, M | 1 |
| Dufour, JP | 1 |
| Esselinckx, W | 1 |
| Melick, RA | 1 |
| Lander, PH | 1 |
| Brown, M | 1 |
| Gargano, F | 1 |
| Blanksma, HJ | 1 |
| Dahlinghaus-Nienhuys, PJ | 1 |
| Gray, RE | 4 |
| Bevington, A | 2 |
| Mundy, KI | 1 |
| Taylor, DJ | 1 |
| Rajagopalan, B | 1 |
| Radda, GK | 1 |
| Beneton, MN | 2 |
| Laponche, AM | 1 |
| Gibbs, CJ | 2 |
| Aaron, JE | 1 |
| Peacock, M | 2 |
| Murray, SA | 2 |
| Hamdy, NA | 2 |
| Urwin, GH | 3 |
| Mautalen, C | 1 |
| Gonzalez, D | 1 |
| Blumenfeld, EL | 1 |
| Santini Araujo, E | 1 |
| Forth, W | 1 |
| Fedou, P | 1 |
| Codine, P | 1 |
| Simon, L | 1 |
| Challa, A | 1 |
| Noorwali, AA | 1 |
| Percival, RC | 1 |
| Williams, JL | 1 |
| Sieghart, S | 1 |
| McCloskey, EV | 1 |
| Delmas, P | 2 |
| Charhon, S | 2 |
| Salson, C | 1 |
| Monk, BE | 1 |
| Cundy, TF | 1 |
| Wilder-Smith, CH | 1 |
| Raue, F | 1 |
| Holz-Gottswinter, G | 1 |
| Heath, DA | 1 |
| Collins-Yudiskas, B | 1 |
| Anderson, DC | 2 |
| Cantrill, JA | 1 |
| Jawad, AS | 1 |
| Berry, H | 1 |
| Muir, HG | 1 |
| Schabort, I | 1 |
| Hough, FS | 1 |
| Dodd, GW | 1 |
| Wattie, D | 1 |
| Lawson-Matthew, PJ | 1 |
| Guilland-Cumming, DF | 1 |
| Frank, K | 1 |
| Ziewacz, JT | 1 |
| Slavin, JD | 1 |
| Spencer, RP | 1 |
| O'Donoghue, DJ | 1 |
| Rico, H | 1 |
| Hernández, ER | 1 |
| Younes, M | 1 |
| Hernández, D | 1 |
| Espinós, D | 1 |
| Lando, M | 1 |
| Hoover, LA | 1 |
| Finerman, G | 1 |
| Ralston, SH | 1 |
| Cowan, RA | 1 |
| Jenkins, A | 1 |
| Wendling, D | 1 |
| Guidet, M | 1 |
| Stutzmann, JJ | 1 |
| Petrovic, AG | 1 |
| Seret, P | 1 |
| Hurez, D | 1 |
| Dewis, P | 1 |
| Prasad, BK | 1 |
| Willets, S | 1 |
| Kovarik, J | 1 |
| Niebauer, B | 1 |
| Woloszczuk, W | 1 |
| Frühwald, F | 1 |
| Kolbe, H | 1 |
| Walton, KR | 1 |
| Green, JR | 1 |
| Reeve, J | 1 |
| Wootton, R | 1 |
| Gritten, C | 2 |
| Diverse, P | 2 |
| Hauwaert, PC | 1 |
| Crielaard, JM | 1 |
| Halleux, R | 2 |
| Franchimont, P | 2 |
| Hauwaert, C | 1 |
| Bourke, J | 1 |
| Murphy, M | 1 |
| Fennelly, JJ | 1 |
| García Vadillo, A | 1 |
| Rodríguez García, A | 1 |
| Elena Ibáñez, A | 1 |
| Castro Beiras, JM | 1 |
| Rodríguez Torrás, M | 1 |
| Mimura, K | 1 |
| Preston, C | 1 |
| Woods, CG | 2 |
| Wellman, H | 1 |
| Serafini, AN | 2 |
| Sankey, RR | 2 |
| Bonjour, JP | 1 |
| Bishop, MC | 1 |
| Bishop, M | 1 |
| Vaisrub, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420] | Phase 1 | 4 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
36 reviews available for etidronate and Osteitis Deformans
| Article | Year |
|---|---|
Paget disease of bone: therapeutic options.
Topics: Alendronate; Alkaline Phosphatase; Anti-Inflammatory Agents; Diphosphonates; Etidronic Acid; Humans; | 2008 |
[Treatment of osteoporosis with etidronate].
Topics: Adenosine Triphosphate; Arthralgia; Bone Density; Clinical Trials as Topic; Energy Metabolism; Etidr | 2004 |
[Pharmacological treatment of osteitis deformans (Paget's bone disease)].
Topics: Alendronate; Analgesics, Non-Narcotic; Antimetabolites; Calcitonin; Clodronic Acid; Diphosphonates; | 2005 |
[Paget's disease and its therapeutic management].
Topics: Administration, Oral; Alkaline Phosphatase; Biomarkers; Diphosphonates; Etidronic Acid; Follow-Up St | 2005 |
[Paget's disease of bone].
Topics: Adaptor Proteins, Signal Transducing; Alkaline Phosphatase; Biomarkers; Bone Density Conservation Ag | 2005 |
Pharmacological therapy of Paget's and other metabolic bone diseases.
Topics: Bone Density Conservation Agents; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Etidron | 2006 |
[Therapeutic effects of risedronate on Paget's disease of bone].
Topics: Aged; Bone Density Conservation Agents; Clinical Trials as Topic; Etidronic Acid; Humans; Male; Oste | 2006 |
[Paget's disease of bone].
Topics: Alkaline Phosphatase; Biomarkers; Bone Density Conservation Agents; Calcitonin; Diagnostic Imaging; | 2007 |
A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Disease Progression; Etidronic Acid; Humans; | 2008 |
Paget's disease of bone: diagnosis and management.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteiti | 1981 |
Experimental basis for the clinical use of diphosphonates in Paget's disease of bone.
Topics: Animals; Bone and Bones; Calcification, Physiologic; Calcium Phosphates; Chemical Phenomena; Chemist | 1980 |
Etidronate disodium in the treatment of Paget's disease of bone.
Topics: Bone Resorption; Calcitonin; Clinical Trials as Topic; Diphosphates; Drug Evaluation; Etidronic Acid | 1982 |
Treatment of Paget's disease.
Topics: Adult; Aged; Alkaline Phosphatase; Animals; Bone and Bones; Bone Neoplasms; Calcitonin; Drug Therapy | 1982 |
Paget's disease of bone.
Topics: Calcitonin; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Osteitis Deformans; O | 1981 |
Calcitonin and diphosphonate in the treatment of Paget's disease of bone.
Topics: Calcitonin; Calcium; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Osteitis Def | 1981 |
Paget's disease of the bone.
Topics: Aged; Calcitonin; Etidronic Acid; Humans; Osteitis Deformans | 1994 |
Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Topics: Bone Diseases; Bone Remodeling; Bone Resorption; Clinical Trials as Topic; Drug Administration Sched | 1994 |
[Paget's disease of bone and basilar impression associated with an Arnold-Chiari type-1 malformation].
Topics: Aged; Arnold-Chiari Malformation; Etidronic Acid; Female; Humans; Osteitis Deformans; Platybasia; Re | 1997 |
Prediction and assessment of the response of Paget's disease to bisphosphonate treatment.
Topics: Alkaline Phosphatase; Bone Resorption; Diphosphonates; Etidronic Acid; Half-Life; Humans; Osteitis D | 1999 |
The use of risedronate in Paget's disease.
Topics: Alkaline Phosphatase; Bone Resorption; Clinical Trials as Topic; Etidronic Acid; Fibrous Dysplasia, | 1999 |
[The potentials for using xidifon in diseases of the locomotor system].
Topics: Diphosphonates; Etidronic Acid; Humans; Musculoskeletal Diseases; Osteitis Deformans; Osteoporosis; | 2000 |
Risedronate: a clinical review.
Topics: Animals; Bone and Bones; Bone Density; Breast Neoplasms; Calcium Channel Blockers; Etidronic Acid; F | 2001 |
Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000.
Topics: Alendronate; Alkaline Phosphatase; Clinical Trials as Topic; Diphosphonates; Etidronic Acid; Humans; | 2001 |
Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease.
Topics: Bone and Bones; Bone Density; Calcium Channel Blockers; Etidronic Acid; Female; Half-Life; Humans; I | 2001 |
Risedronate: clinical usage.
Topics: Bone Density; Bone Resorption; Calcium Channel Blockers; Etidronic Acid; Female; Humans; Male; Ostei | 2001 |
The diagnosis of Paget's disease.
Topics: Aged; Alkaline Phosphatase; Biomarkers; Diphosphonates; Etidronic Acid; Female; Humans; Male; Osteit | 2001 |
Risedronate: a new oral bisphosphonate.
Topics: Administration, Oral; Alendronate; Calcium Channel Blockers; Diphosphonates; Etidronic Acid; Female; | 2001 |
[Risedronate: clinical usage].
Topics: Bone Density; Clinical Trials as Topic; Etidronic Acid; Femoral Neck Fractures; Fractures, Stress; H | 2002 |
Paget's disease of bone.
Topics: Bone and Bones; Calcitonin; Calcium; Collagen; Etidronic Acid; Humans; Hydroxylysine; Hydroxyproline | 1977 |
Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
Topics: Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcium; Deafness; Etidronic Acid; Fractures, Bone | 1977 |
Etidronate for hypercalcemia of malignancy and osteoporosis.
Topics: Etidronic Acid; Humans; Hypercalcemia; Neoplasms; Ossification, Heterotopic; Osteitis Deformans; Ost | 1991 |
Treatment of Paget's disease of bone.
Topics: Analgesics; Antibody Formation; Calcitonin; Diphosphonates; Drug Resistance; Drug Therapy, Combinati | 1985 |
Paget's disease: state of the art.
Topics: Alkaline Phosphatase; Calcitonin; Etidronic Acid; Humans; Hydroxyproline; Osteitis Deformans; Plicam | 1987 |
Dynamic radiologic patterns of Paget's disease of bone.
Topics: Biomechanical Phenomena; Bone and Bones; Bone Development; Bone Resorption; Calcitonin; Diphosphonat | 1987 |
Treating Paget's disease.
Topics: Calcitonin; Etidronic Acid; Forecasting; Humans; Osteitis Deformans; Recurrence | 1987 |
[Biphosphonate as a therapeutic drug--experimental studies and clinical application].
Topics: Animals; Calcinosis; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperpar | 1985 |
34 trials available for etidronate and Osteitis Deformans
| Article | Year |
|---|---|
Efficacy, tolerability, and safety of risedronate in Japanese patients with Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Etidronic Acid; Female; Humans; Ma | 2010 |
Midterm outcome of risedronate therapy for patients with Paget's disease of bone in the central part of Japan.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Bone Density Conservation Agen | 2013 |
Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Remodeling; Dipho | 2005 |
Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
Topics: Administration, Oral; Adult; Bone Density Conservation Agents; Diphosphonates; Dose-Response Relatio | 2006 |
Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Bone Density Co | 2007 |
Etidronate disodium in the treatment of Paget's disease of bone.
Topics: Bone Resorption; Calcitonin; Clinical Trials as Topic; Diphosphates; Drug Evaluation; Etidronic Acid | 1982 |
Paget's disease of bone.
Topics: Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate | 1982 |
[Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
Topics: Adult; Aged; Alkaline Phosphatase; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Hormones; | 1981 |
Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy.
Topics: Calcitonin; Clinical Trials as Topic; Double-Blind Method; Etidronic Acid; Humans; Osteitis Deforman | 1981 |
Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Dose-Response Relationship, Dr | 1995 |
Risedronate in Paget's disease: preliminary results of a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Etidronic Acid; Humans; Middle Age | 1994 |
Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
Topics: Alkaline Phosphatase; Calcitonin; Creatinine; Diphosphonates; Drug Administration Schedule; Drug Res | 1993 |
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Amino Acids | 1996 |
Biological and radiological responses to oral etidronate and tiludronate in Paget's disease of bone.
Topics: Administration, Oral; Aged; Diphosphonates; Double-Blind Method; Drug Monitoring; Etidronic Acid; Fe | 1997 |
Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Calcium Chan | 1998 |
Risedronate, a highly effective, short-term oral treatment for Paget's disease: a dose-response study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Calcium Channel Blockers; Consumer Product Safety; Do | 1999 |
Treatment of Paget's disease of bone with alendronate.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Bone Resorption; Etidronic Acid; | 1999 |
A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Calcium Channel Blockers; Double-B | 1999 |
Diphosphonate therapy of paget's disease of bone.
Topics: Alkaline Phosphatase; Clinical Trials as Topic; Dose-Response Relationship, Drug; Etidronic Acid; Fe | 1977 |
Calcitonin or EHDP in Paget's disease?
Topics: Bone and Bones; Calcitonin; Calcium; Clinical Trials as Topic; Etidronic Acid; Humans; Osteitis Defo | 1977 |
Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Matrix; Clinical Trials as Topic; Etidronic | 1977 |
Radionuclide uptake studies of bone: a quantitative method of evaluating the response of patients with Paget's disease to diphosphonate therapy.
Topics: Clinical Trials as Topic; Drug Evaluation; Etidronic Acid; Humans; Organophosphorus Compounds; Ostei | 1975 |
Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
Topics: Alkaline Phosphatase; Calcitonin; Clinical Trials as Topic; Drug Therapy, Combination; Etidronic Aci | 1976 |
Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Clinical Trials as Topic; Clodro | 1987 |
Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.
Topics: Aged; Bone and Bones; Etidronic Acid; Female; Humans; Male; Middle Aged; Minerals; Osteitis Deforman | 1986 |
Short term high doses of etidronate in Paget's disease of bone.
Topics: Etidronic Acid; Humans; Osteitis Deformans; Time Factors | 1986 |
[Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
Topics: Alkaline Phosphatase; Etidronic Acid; Female; Humans; Long-Term Care; Male; Middle Aged; Osteitis De | 1986 |
Contrasting effects of intravenous and oral etidronate on vitamin D metabolism in man.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bone and Bones; Calcium; Etidronic Acid; Female; Huma | 1988 |
The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
Topics: Alkaline Phosphatase; Calcitriol; Creatinine; Double-Blind Method; Etidronic Acid; Humans; Hydroxypr | 1987 |
Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
Topics: Aged; Alkaline Phosphatase; Clinical Trials as Topic; Creatinine; Diphosphonates; Etidronic Acid; Hu | 1985 |
Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone.
Topics: Aged; Alkaline Phosphatase; Clinical Trials as Topic; Drug Resistance; Etidronic Acid; Female; Follo | 1985 |
Diphosphonates in Paget's disease.
Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Resorption; Calcium; Clinic | 1974 |
Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Clinical Trials as Topic; Dose-Res | 1973 |
Treatment of Paget disease of bone (osteitis deformans). Results of a one-year study with sodium etidronate.
Topics: Age Factors; Aged; Alkaline Phosphatase; Clinical Trials as Topic; Drug Evaluation; Etidronic Acid; | 1974 |
185 other studies available for etidronate and Osteitis Deformans
| Article | Year |
|---|---|
History of etidronate.
Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; History, 20t | 2020 |
Dental implants in a patient with Paget disease under bisphosphonate treatment: a case report.
Topics: Administration, Oral; Bone Density Conservation Agents; Dental Implantation, Endosseous; Dental Pros | 2009 |
Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy.
Topics: Aged; Alveolar Bone Loss; Bone Density Conservation Agents; Dental Implantation, Endosseous; Dental | 2009 |
Diagnosis of Paget's disease of the pelvis using F-18 FDG PET/CT.
Topics: Asymptomatic Diseases; Bone Density Conservation Agents; Diagnosis, Differential; Etidronic Acid; Fe | 2010 |
Paget disease of bone - an update.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Diphosphonates; Etidronic Ac | 2012 |
Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
Topics: Aged, 80 and over; Alkaline Phosphatase; Biopsy; Bone Density Conservation Agents; Calcification, Ph | 2012 |
Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.
Topics: Angiogenesis Inhibitors; Animals; Bone and Bones; Cell Division; Cells, Cultured; Clodronic Acid; Di | 2002 |
Two cases of monostotic Paget's disease: effects of bisphosphonate.
Topics: Aged; Alendronate; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Remodeling; Diphosphonates | 2003 |
Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
Topics: Administration, Oral; Alkaline Phosphatase; Calcitriol; Clodronic Acid; Diphosphonates; Drug Toleran | 2004 |
Monostotic Paget's disease of the tibia in Korea.
Topics: Alkaline Phosphatase; Calcitonin; Calcium; Combined Modality Therapy; Etidronic Acid; Female; Humans | 2004 |
Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: relationship to risedronate treatment.
Topics: Aged; Etidronic Acid; Female; Glycoproteins; Humans; Interleukin-6; Male; Middle Aged; Osteitis Defo | 2005 |
Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Bone Density Conservation Agents; | 2005 |
Paget's disease and bisphosphonates.
Topics: Administration, Oral; Alendronate; Cost-Benefit Analysis; Diphosphonates; Drug Administration Schedu | 2005 |
Paget's disease and bisphosphonates.
Topics: Administration, Oral; Alkaline Phosphatase; Diphosphonates; Disease Progression; Etidronic Acid; Hum | 2005 |
[Optimizing therapy in Paget disease].
Topics: Administration, Oral; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; E | 2005 |
Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
Topics: Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Humans; Hy | 2006 |
[Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly].
Topics: Aged; Aged, 80 and over; Alendronate; Biological Availability; Bone Density Conservation Agents; Dip | 2006 |
[A young woman with headaches and skull anomalies: a long road to the diagnosis 'Paget's disease'].
Topics: Adult; Alkaline Phosphatase; Bone Density Conservation Agents; Diagnosis, Differential; Etidronic Ac | 2006 |
Multiple fractures in a woman receiving 24 years of etidronate treatment for Paget's disease.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Fractures, Spontaneo | 2007 |
[Radius shaft fracture in a 31-year old man].
Topics: Adult; Bone Density Conservation Agents; Etidronic Acid; Humans; Male; Osteitis Deformans; Radiograp | 2008 |
Diphosphonates: aimed in a chemical sense.
Topics: Bone and Bones; Bone Diseases, Metabolic; Bone Resorption; Diphosphonates; Etidronic Acid; Humans; M | 1981 |
Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.
Topics: Aged; Biopsy; Bone and Bones; Bone Resorption; Etidronic Acid; Female; Humans; Male; Middle Aged; Mi | 1984 |
Mithramycin treatment of Paget's disease of bone. Exploration of combined mithramycin-EHDP therapy.
Topics: Aged; Alkaline Phosphatase; Antibiotics, Antineoplastic; Binding, Competitive; Dactinomycin; Drug Th | 1980 |
[Clinical aspects and therapy of Paget's disease (osteitis deformans)].
Topics: Adult; Aged; Alkaline Phosphatase; Calcitonin; Diphosphonates; Etidronic Acid; Exercise Therapy; Hum | 1983 |
Observations on serial radionuclide blood-flow studies in Paget's disease: concise communication.
Topics: Alkaline Phosphatase; Bone and Bones; Calcitonin; Diphosphonates; Drug Therapy, Combination; Etidron | 1983 |
Diagnosis and treatment of Paget's disease of bone.
Topics: Calcitonin; Etidronic Acid; Female; Humans; Male; Osteitis Deformans; Plicamycin | 1983 |
Pathophysiology and modern management of Paget's disease.
Topics: Calcitonin; Etidronic Acid; Humans; Osteitis Deformans; Osteoblasts; Osteoclasts; Plicamycin | 1983 |
Osteoporosis, osteomalacia, rickets, and Paget's disease.
Topics: Anti-Inflammatory Agents; Calcitonin; Calcium; Diet; Estrogens; Etidronic Acid; Humans; Osteitis Def | 1984 |
[Paget disease of the skeleton. Internal medicine aspects].
Topics: Alkaline Phosphatase; Calcitonin; Calcium; Diagnosis, Differential; Etidronic Acid; Humans; Hydroxyp | 1984 |
[Studies of the kinetics of bone concentration of mdp-tc 99m in Paget's disease and various treatment methods].
Topics: Adult; Bone and Bones; Calcitonin; Diphosphonates; Etidronic Acid; Female; Humans; Male; Middle Aged | 1984 |
[Paget's disease of bone].
Topics: Bone and Bones; Cyclic AMP; Etidronic Acid; Humans; Osteitis Deformans; Radionuclide Imaging | 1981 |
Hyperparathyroidism in Paget's disease of bone.
Topics: Aged; Calcium; Cyclic AMP; Etidronic Acid; Female; Humans; Hyperparathyroidism; Male; Middle Aged; O | 1983 |
Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
Topics: Adult; Aged; Alkaline Phosphatase; Blood Chemical Analysis; Cell Count; Drug Evaluation; Etidronic A | 1983 |
Treatment of Paget's disease of bone.
Topics: Aged; Alkaline Phosphatase; Calcitonin; Calcium; Chlorthalidone; Dose-Response Relationship, Drug; E | 1983 |
[Value of the therapeutic sequence calcitonin-EHDP in Paget's disease].
Topics: Aged; Calcitonin; Drug Administration Schedule; Drug Therapy, Combination; Etidronic Acid; Female; H | 1983 |
Diphosphonates and painful feet.
Topics: Diphosphonates; Etidronic Acid; Female; Foot Diseases; Humans; Male; Middle Aged; Osteitis Deformans | 1983 |
Paget's disease of bone.
Topics: Etidronic Acid; Fractures, Spontaneous; Humans; Osteitis Deformans | 1983 |
Pathologic fracture due to severe osteomalacia following low-dose diphosphonate treatment of Paget's disease of bone.
Topics: Etidronic Acid; Fractures, Spontaneous; Humans; Male; Middle Aged; Osteitis Deformans; Osteomalacia; | 1983 |
[Etidronic acid therapy in Paget's disease of bone].
Topics: Alkaline Phosphatase; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Male; O | 1983 |
Disodium etidronate (EHDP)
Topics: Etidronic Acid; Fractures, Spontaneous; Humans; Osteitis Deformans; Osteomalacia | 1984 |
[Pseudosarcomatous osteolysis in a Paget's disease patient treated with disodium etidronate (EHDP)].
Topics: Bone Neoplasms; Bone Resorption; Calcitonin; Diagnosis, Differential; Etidronic Acid; Humans; Male; | 1984 |
Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology.
Topics: Aged; Antigens, Viral; Bone and Bones; Etidronic Acid; Female; Humans; Male; Measles virus; Middle A | 1984 |
Alternate calcitonin and etidronate disodium therapy for Paget's bone disease.
Topics: Aged; Alkaline Phosphatase; Calcitonin; Drug Administration Schedule; Drug Therapy, Combination; Eti | 1984 |
Treatment of Paget's bone disease with the bisphosphonate APD.
Topics: Aged; Alkaline Phosphatase; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Mi | 1983 |
Photon-deficient bone scan lesion as a precursor of active Paget's disease.
Topics: Aged; Bone and Bones; Etidronic Acid; Female; Humans; Organotechnetium Compounds; Osteitis Deformans | 1984 |
Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Drug Interactions; Etidronic Acid; | 1984 |
Current concepts of Paget's disease of bone.
Topics: Arthritis; Calcitonin; Etidronic Acid; Fractures, Spontaneous; Humans; Joint Prosthesis; Osteitis De | 1984 |
Monitoring the treatment of Paget's disease with etidronate.
Topics: Etidronic Acid; Humans; Osteitis Deformans | 1984 |
Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
Topics: Aged; Alkaline Phosphatase; Calcitonin; Calcium; Diphosphonates; Drug Therapy, Combination; Etidroni | 1984 |
New diphosphonates to block bone resorption.
Topics: Animals; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Double-Blind Method; Eti | 1980 |
APD in Paget's disease of bone. Role of the mononuclear phagocyte system?
Topics: Animals; Arthritis, Rheumatoid; Calcitonin; Clodronic Acid; Diphosphonates; Drug Therapy, Combinatio | 1980 |
Bone scintigraphy in evaluation of Didronel therapy for Paget's disease.
Topics: Bone and Bones; Diphosphonates; Etidronic Acid; Follow-Up Studies; Humans; Male; Middle Aged; Osteit | 1981 |
Effects of two diphosphonates (EHDP and Cl2MDP) on serum uric acid in pagetic patients.
Topics: Adult; Aged; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; H | 1981 |
Paget disease: a review of current knowledge.
Topics: Aged; Biopsy; Calcitonin; Etidronic Acid; Humans; Osteitis Deformans; Plicamycin; Radiography | 1981 |
Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis?
Topics: Adult; Aged; Calcitonin; Clodronic Acid; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis | 1981 |
Use of etidronate (EHDP) in Paget's disease of bone.
Topics: Actuarial Analysis; Alkaline Phosphatase; Dose-Response Relationship, Drug; Etidronic Acid; Female; | 1980 |
Long-term therapy of Paget's disease of bone with EHDP.
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Etidronic Acid; Female; Humans; Hydroxyproline; Long-Ter | 1980 |
[Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydro | 1980 |
An apparent 1,25-dihydroxyvitamin D-independent stimulation of intestinal calcium absorption in patients with Paget disease of bone during a short-term diphosphonate therapy.
Topics: Aged; Alkaline Phosphatase; Calcitriol; Calcium; Dihydroxycholecalciferols; Etidronic Acid; Female; | 1981 |
A critical assessment of bone scan quantitation (bone to soft tissue ratios) in the diagnosis of metabolic bone disease.
Topics: Adult; Aged; Aging; Bone and Bones; Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bon | 1981 |
[Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
Topics: Aged; Alkaline Phosphatase; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Female; Humans; H | 1981 |
Effect of sodium etidronate and phenytoin of Pagetic bone.
Topics: Aged; Calcitonin; Etidronic Acid; Humans; Male; Osteitis Deformans; Phenytoin; Seizures | 1981 |
Paget's disease of bone.
Topics: Etidronic Acid; Glucagon; Humans; Osteitis Deformans | 1981 |
An unusual morphologic evolution of Paget's disease of bone.
Topics: Calcitonin; Etidronic Acid; Femur; Humans; Male; Middle Aged; Osteitis Deformans; Pelvis; Radiograph | 1981 |
[Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Calcitonin; Drug Therapy, Combination; Etidronic | 1982 |
[Treatment of Paget's disease with 1-ethane-1-hydroxy-1-diphosphonate].
Topics: Aged; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis Deformans | 1982 |
Effect of sodium etidronate and phenytoin on Pagetic bone.
Topics: Calcitonin; Etidronic Acid; Humans; Osteitis Deformans | 1982 |
Etidronate-an oral treatment for Paget's disease of bone.
Topics: Administration, Oral; Etidronic Acid; Humans; Osteitis Deformans | 1982 |
[Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
Topics: Aged; Alkaline Phosphatase; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Female; Humans; H | 1982 |
Bone scintigraphy in Paget's disease treated with combined calcitonin and diphosphonate (EHDP).
Topics: Bone and Bones; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Humans; Osteitis Deformans; R | 1982 |
Effects of ethane-1 hydroxy-1, 1-diphosphonate (5 mg/kg/day dose) on quantitative bone histology in Paget's disease of bone.
Topics: Adult; Aged; Biopsy; Bone Resorption; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis De | 1981 |
Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Resorption; Chromatography, | 1995 |
Treatment of Paget's disease of bone with bisphosphonates.
Topics: Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate | 1995 |
Tracer flows and 'difficult' organs.
Topics: Bone and Bones; Diphosphonates; Etidronic Acid; Humans; Kidney; Kinetics; Models, Biological; Models | 1995 |
Paget's disease of bone.
Topics: Bone Resorption; Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans | 1994 |
[Differences in the cellular response of the immune system in patients with Paget's disease of bone after elcatonin and etidronate administration].
Topics: Aged; Biomarkers; Bone Remodeling; Calcitonin; CD4-CD8 Ratio; Drug Evaluation; Etidronic Acid; Femal | 1994 |
Extensive personal experience: Paget's disease of bone.
Topics: Animals; Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pain; Pamidronate; | 1995 |
Monostotic localization of Paget disease in the hand.
Topics: Aged; Etidronic Acid; Humans; Male; Organotechnetium Compounds; Osteitis Deformans; Radionuclide Ima | 1994 |
Hereditary hyperphosphatasia: 20 year follow-up and response to disodium etidronate.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Etidronic Acid; Family; Female; Follow-Up Studies; Huma | 1994 |
Therapeutic strategy in Paget's disease of bone.
Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Analgesics, Non-Narcotic; Biomarkers; Bone | 1995 |
[Biphosphonates].
Topics: Bone Diseases, Metabolic; Bone Neoplasms; Bone Resorption; Diphosphonates; Etidronic Acid; Humans; O | 1996 |
[Pseudosarcomatous osteolysis of the femur in a patient with Paget's bone disease treated with long-term etidronate disodium: apropos of a new case].
Topics: Aged; Etidronic Acid; Femur; Humans; Male; Osteitis Deformans; Osteolysis; Time Factors | 1996 |
Paget's disease of bone: reduction of disease activity with oral risedronate.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Calcium Channel Blocke | 1998 |
Changes in bone mineral density in patients with Paget's disease treated with risedronate.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Bone Density; Bone Remodeling; Calcium Channel Bloc | 1997 |
Focal osteolysis as a complication of therapy for Paget's disease: case report.
Topics: Acetabulum; Antibiotics, Antineoplastic; Arthroplasty, Replacement, Hip; Bone Remodeling; Calcitonin | 1998 |
Risedronate released for Paget's disease.
Topics: Calcium Channel Blockers; Drug Approval; Etidronic Acid; Humans; Osteitis Deformans; Risedronic Acid | 1998 |
Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitriol; Calcium; Calcium Channel Blockers; Creati | 1998 |
Risedronate for Paget's disease of bone.
Topics: Administration, Oral; Aged; Bone Resorption; Calcium Channel Blockers; Clinical Trials as Topic; Dia | 1998 |
A patient with Paget's disease of bone treated with etidronate disodium.
Topics: Aged; Alkaline Phosphatase; Etidronic Acid; Female; Humans; Hydroxyproline; Osteitis Deformans | 1998 |
New drugs 99, Part III.
Topics: Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Antibodies, Monoclonal; Antibodies, Monoclona | 1999 |
Improvement of pagetic bone lesions with risedronate treatment: a radiologic study.
Topics: Aged; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis Deformans; Radiography; Risedronic | 2000 |
Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
Topics: Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthralgia; Diphosphonates; Etidronic Acid; Fo | 2000 |
[Risedronate, a new diphosphonate in osteoporosis and Paget's disease].
Topics: Aged; Calcium Channel Blockers; Cortisone; Costs and Cost Analysis; Double-Blind Method; Etidronic A | 2002 |
Letter: Disodium ethane-1-hydroxy-1, 1-diphosphonate(E.H.D.P.) in Paget's disease.
Topics: Etidronic Acid; Humans; Organophosphorus Compounds; Osteitis Deformans | 1975 |
Paget's bone disease treated with diphosphonate and calcitonin.
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Calcitonin; Drug Evaluation; Drug Therapy, Combination; | 1976 |
Letter: Diphosphonate and calcitonin in Paget's disease.
Topics: Calcitonin; Drug Therapy, Combination; Etidronic Acid; Humans; Organophosphorus Compounds; Osteitis | 1976 |
Ten years' treatment for Paget's disease.
Topics: Calcitonin; Calcium; Drug Evaluation; Etidronic Acid; Hormones; Humans; Osteitis Deformans; Parathyr | 1978 |
Etidronate disodium for Paget's disease.
Topics: Calcitonin; Etidronic Acid; Humans; Osteitis Deformans | 1978 |
Medical staff conference. Paget disease of bone.
Topics: Calcitonin; Etidronic Acid; Humans; Osteitis Deformans | 1978 |
"The chemistry of bone mineral".
Topics: Adenosine Triphosphate; Animals; Bone and Bones; Bone Matrix; Calcification, Physiologic; Calcium Ph | 1978 |
[The hypocalcemia test, using human and salmon synthetic calcitonins. Paradoxical hypercalcemic responses. Responses in patients with Paget's disease treated with EHDP].
Topics: Calcitonin; Calcium; Dose-Response Relationship, Drug; Etidronic Acid; Hormones; Humans; Hyperparath | 1979 |
Treatment of Paget's disease of bone.
Topics: Alkaline Phosphatase; Calcitonin; Etidronic Acid; Humans; Hydroxyproline; Injections, Intravenous; I | 1975 |
Paget's disease: New treatment for an old disease.
Topics: Calcitonin; Etidronic Acid; Humans; Osteitis Deformans; Plicamycin; United States | 1976 |
[Non-hormonal drug treatment in Paget's disease].
Topics: Alkaline Phosphatase; Etidronic Acid; Humans; Hydroxyproline; Organophosphorus Compounds; Osteitis D | 1975 |
Current diagnosis and management of Paget's disease of bone.
Topics: Calcitonin; Dactinomycin; Etidronic Acid; Glucagon; Humans; Osteitis Deformans; Plicamycin | 1977 |
Paget's disease of bone.
Topics: Adult; Bone and Bones; Calcitonin; Calcium; Collagen; Dactinomycin; Etidronic Acid; Fluorides; Gluca | 1977 |
[Paget's disease of bone].
Topics: Aged; Bone Resorption; Calcitonin; Etidronic Acid; Female; Humans; Inclusion Bodies, Viral; Male; Mi | 1979 |
Paget's disease of bone: assessment and management.
Topics: Aged; Alkaline Phosphatase; Analgesics; Calcitonin; Etidronic Acid; Humans; Hydroxyproline; Middle A | 1979 |
[Treatment of Paget's disease paraplegia with diphosphonates : preliminary results (author's transl)].
Topics: Aged; Calcitonin; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Male; Middle Aged; | 1979 |
[Drug therapy of Paget's disease (osteodystrophia deformans)].
Topics: Adrenocorticotropic Hormone; Antineoplastic Agents; Aspirin; Calcitonin; Calcium; Cortisone; Etidron | 1976 |
Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets.
Topics: Etidronic Acid; Humans; Hyperparathyroidism; Hypophosphatemia, Familial; Kidney; Kidney Tubules; Org | 1976 |
Paget's disease and the nervous system.
Topics: Adult; Alkaline Phosphatase; Calcitonin; Etidronic Acid; Humans; Hydrocephalus; Hydroxyproline; Midd | 1979 |
Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
Topics: Adolescent; Adult; Amino Acids; Bone and Bones; Burns; Calcitonin; Child; Collagen; Etidronic Acid; | 1977 |
Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease.
Topics: Adult; Aged; Bone and Bones; Bone Resorption; Calcium; Etidronic Acid; Female; Histocytochemistry; H | 1977 |
Bone scan appearance of a Paget's osteosarcoma: failure to concentrate HEDP.
Topics: Bone Neoplasms; Etidronic Acid; Female; Humans; Middle Aged; Osteitis Deformans; Osteosarcoma; Radio | 1977 |
Quantitative bone histology in Paget's disease of bone: influence of sodium etidronate (EHDP) therapy.
Topics: Bone and Bones; Etidronic Acid; Humans; Osteitis Deformans; Osteoclasts | 1977 |
Skeletal scintimaging and radiography in the diagnosis and management of Paget's disease.
Topics: Alkaline Phosphatase; Bone and Bones; Diagnosis, Differential; Etidronic Acid; Humans; Osteitis Defo | 1977 |
Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Mi | 1975 |
[Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Etidronic Acid; Humans; Hydroxyproline; Organophospho | 1976 |
[Clinical, biological and histological effects of ethane-1-hydroxy 1, 1-diphosphonate (EDHP) in Paget's disease].
Topics: Alkaline Phosphatase; Bone and Bones; Etidronic Acid; Humans; Hydroxyproline; Organophosphorus Compo | 1975 |
Radioimmunoassay of procollagen in serum of patients with Paget's disease of bone.
Topics: Adult; Aged; Collagen; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis Deformans; Protei | 1976 |
Evaluation of scintigraphic and roentgenologic studies in Paget's disease under treatment.
Topics: Alkaline Phosphatase; Etidronic Acid; Evaluation Studies as Topic; Humans; Osteitis Deformans; Radio | 1976 |
Serum proline imino-peptidase activity in normal adult subjects and in patients with Paget's disease of bone.
Topics: Adult; Aged; Alkaline Phosphatase; Aminopeptidases; Dietary Proteins; Etidronic Acid; Female; Gelati | 1976 |
New treatments of Paget's disease.
Topics: Calcitonin; Etidronic Acid; Humans; Osteitis Deformans | 1976 |
[Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
Topics: Aged; Alkaline Phosphatase; Biopsy; Bone and Bones; Etidronic Acid; Female; Humans; Hydroxyproline; | 1976 |
[The long-term results of ethanehydroxydiphosphonate treatment in Paget's disease of bone].
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Evaluation; Etidronic Acid; F | 1991 |
Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
Topics: 24,25-Dihydroxyvitamin D 3; Aged; Alkaline Phosphatase; Calcifediol; Calcitonin; Calcitriol; Calcium | 1990 |
Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment.
Topics: Aged; Aged, 80 and over; Diphosphonates; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis | 1990 |
[Paget's disease: a case history, clinical and therapeutic contribution].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone and Bones; Calcitonin; Etidronic Acid; Female; Fibrous | 1990 |
Improvement in the deformity of the face in Paget's disease treated with diphosphonates.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Cephalometry; Clodronic Acid; Diphosphonates; Etidron | 1990 |
Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
Topics: Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hydroxyproline; Inclus | 1985 |
[Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate].
Topics: Adult; Aged; Alkaline Phosphatase; Drug Administration Schedule; Drug Resistance; Etidronic Acid; Fe | 1989 |
[Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitonin; Diphosphonates; Drug Administratio | 1989 |
Vitamin D in Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitonin; Calcium; Etidronic Acid; Female; Humans; | 1989 |
[Paget's disease: errors to be avoided].
Topics: Adult; Alkaline Phosphatase; Calcitonin; Diagnostic Errors; Etidronic Acid; Humans; Hydroxyproline; | 1989 |
Clinical and radiographic improvement of bone of the second lumbar vertebra in Paget's disease following therapy with etidronate disodium: a case report.
Topics: Etidronic Acid; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteitis Deformans; Radiography; Time F | 1989 |
[Treatment of Paget's disease].
Topics: Calcitonin; Drug Administration Schedule; Etidronic Acid; Humans; Osteitis Deformans; Plicamycin | 1989 |
'Breaking the back' of Paget's bone disease.
Topics: Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate; Plicamycin | 1989 |
Etidronate and the risk of fractures.
Topics: Aged; Etidronic Acid; Female; Fractures, Spontaneous; Humans; Male; Osteitis Deformans | 1985 |
A dynamic classification of Paget's disease.
Topics: Bone and Bones; Calcitonin; Etidronic Acid; Fractures, Spontaneous; Humans; Osteitis Deformans; Plic | 1986 |
Low back pain in Paget's disease of bone.
Topics: Back Pain; Diagnosis, Differential; Etidronic Acid; Humans; Osteitis Deformans; Osteoarthritis; Radi | 1987 |
Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
Topics: Administration, Oral; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Dose-Response Relationsh | 1987 |
A study of intracellular orthophosphate concentration in human muscle and erythrocytes by 31P nuclear magnetic resonance spectroscopy and selective chemical assay.
Topics: Adult; Erythrocytes; Etidronic Acid; Female; Humans; Hypophosphatemia, Familial; Magnetic Resonance | 1986 |
Effective short term treatment of Paget's disease with oral etidronate.
Topics: Administration, Oral; Alkaline Phosphatase; Bone and Bones; Etidronic Acid; Humans; Hydroxyproline; | 1986 |
Diagnosis and management of Paget's disease.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Calcitonin; Etidronic Acid; Fractures, Bone; Humans; Mi | 1986 |
[Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study].
Topics: Aged; Calcitonin; Drug Administration Schedule; Drug Therapy, Combination; Etidronic Acid; Female; H | 1986 |
Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
Topics: Aged; Etidronic Acid; Female; Femoral Fractures; Femoral Neck Fractures; Fractures, Spontaneous; Hum | 1986 |
Metabolic bone disease and Paget's disease in the elderly. Part II: Paget's disease.
Topics: Aged; Arthritis; Bone and Bones; Calcitonin; Etidronic Acid; Female; Fractures, Spontaneous; Humans; | 1986 |
Short term high doses of etidronate in Paget's disease.
Topics: Alkaline Phosphatase; Etidronic Acid; Humans; Osteitis Deformans | 1986 |
[Diphosphonate for the prevention of an increased ossification process].
Topics: Diphosphonates; Etidronic Acid; Gastrointestinal Diseases; Humans; Ossification, Heterotopic; Osteit | 1986 |
[Pseudotumoral osteolysis caused by diphosphonates].
Topics: Bone Resorption; Etidronic Acid; Female; Humans; Middle Aged; Osteitis Deformans; Osteolysis; Radiog | 1986 |
Cellular phosphate metabolism in patients receiving bisphosphonate therapy.
Topics: Administration, Oral; Chlorides; Diphosphonates; Etidronic Acid; Humans; Infusions, Parenteral; Orga | 1986 |
Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption.
Topics: Aged; Biopsy; Bone Neoplasms; Bone Resorption; Calcitonin; Carcinoma; Etidronic Acid; Humans; Ilium; | 1987 |
Effects of intravenous etidronate disodium on skeletal and calcium metabolism.
Topics: Aged; Bone and Bones; Bone Diseases, Metabolic; Calcium; Etidronic Acid; Female; Humans; Hydroxyprol | 1987 |
Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry.
Topics: Bone and Bones; Calcium; Etidronic Acid; Humans; Hypercalcemia; Osteitis Deformans; Paraneoplastic E | 1987 |
Skeletal distribution and biochemical parameters of Paget's disease.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antibodies; Bone and Bones; Etidronic Acid; Fe | 1987 |
Remission of psoriasis with etidronate treatment of underlying Paget's disease of bone.
Topics: Etidronic Acid; Humans; Leg Dermatoses; Male; Middle Aged; Osteitis Deformans; Psoriasis; Remission, | 1987 |
Procollagen-III peptide serum levels in Paget's disease of the bone.
Topics: Alkaline Phosphatase; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Humans; Hydroxyproline; | 1987 |
Synthetic human calcitonin in refractory Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitonin; Drug Therapy, Combination; Etidronic Acid | 1987 |
Treating Paget's disease.
Topics: Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate | 1987 |
Spinal cord compression in Paget's disease of bone treated medically.
Topics: Aged; Etidronic Acid; Humans; Male; Osteitis Deformans; Spinal Cord Compression | 1987 |
Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate.
Topics: Aged; Aged, 80 and over; Biopsy; Bone and Bones; Diphosphonates; Drug Evaluation; Drug Resistance; E | 1987 |
Influence of disodium etidronate on Paget's disease of bone.
Topics: Adult; Aged; Drug Evaluation; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis Deformans; | 1987 |
Radiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD.
Topics: Aged; Diphosphonates; Etidronic Acid; Female; Femur; Humans; Male; Middle Aged; Osteitis Deformans; | 1987 |
[Therapy of Paget's disease of bone].
Topics: Adult; Aged; Calcitonin; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Female; Humans; | 1988 |
Unusual scintigraphic findings in a case of treated monostotic Paget's disease.
Topics: Aged; Etidronic Acid; Female; Femur; Humans; Osteitis Deformans; Radionuclide Imaging; Technetium Tc | 1988 |
Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
Topics: Alkaline Phosphatase; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Humans; Hydroxyproline; | 1987 |
Biochemical assessment of acute and chronic treatment of Paget's bone disease with calcitonin and calcium with and without biphosphonate.
Topics: Aged; Calcitonin; Calcium; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis Deformans | 1988 |
Stabilization of hearing loss in Paget's disease with calcitonin and etidronate.
Topics: Aged; Alkaline Phosphatase; Calcitonin; Etidronic Acid; Female; Hearing Loss; Humans; Male; Middle A | 1988 |
Osteolytic Paget's disease of bone under unduly etidronate therapy.
Topics: Aged; Etidronic Acid; Humans; Male; Osteitis Deformans; Osteolysis | 1988 |
Diphosphonates for otospongiosis.
Topics: Adult; Bone Development; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Ma | 1985 |
[Treatment of Paget's disease by anti-measles vaccination and high dose etidronate].
Topics: Combined Modality Therapy; Etidronic Acid; Humans; Immunotherapy; Measles Vaccine; Osteitis Deforman | 1985 |
[EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
Topics: Aged; Alkaline Phosphatase; Calcium; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Ag | 1985 |
Reduction of skeletal blood flow in Paget's disease with disodium etidronate therapy.
Topics: Alkaline Phosphatase; Bone and Bones; Calcitonin; Depression, Chemical; Etidronic Acid; Fluorine; Hu | 1985 |
[Treatment of Paget's disease with low dose sodium etidronate (5mg/kg/day). Occurrence of reversible transient suspected leukopenia].
Topics: Aged; Alkaline Phosphatase; Etidronic Acid; Female; Humans; Hydroxyproline; Leukocyte Count; Leukope | 1985 |
[Evolution of Paget's disease of bone during and after treatment with small doses of disodium etidronate (EHDP)].
Topics: Aged; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis Deformans | 1985 |
Paget's disease of bone. An update on management.
Topics: Bone and Bones; Calcitonin; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Ostei | 1985 |
Experience with sodium etidronate in the treatment of symptomatic Paget's disease of bone.
Topics: Etidronic Acid; Humans; Osteitis Deformans | 1985 |
[Usefulness of ethane-hydroxy-diphosphonate in the treatment of Paget's disease].
Topics: Aged; Alkaline Phosphatase; Drug Evaluation; Etidronic Acid; Female; Humans; Hydroxyproline; Male; M | 1985 |
[Treatment of Paget's disease of bone].
Topics: Aged; Blood Chemical Analysis; Bone and Bones; Calcitonin; Etidronic Acid; Female; Follow-Up Studies | 1985 |
Treatment of Paget's disease of bone.
Topics: Animals; Bone Resorption; Calcitonin; Dactinomycin; Etidronic Acid; Glucagon; Humans; Osteitis Defor | 1973 |
Editorial: Diphosphonate treatment in bone disease.
Topics: Adult; Animals; Bone and Bones; Bone Diseases; Calcium; Child; Etidronic Acid; Humans; Myositis Ossi | 1973 |
Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
Topics: Adult; Aged; Alkaline Phosphatase; Biopsy; Bone Resorption; Calcitonin; Calcium; Clinical Enzyme Tes | 1973 |
Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
Topics: Adult; Aged; Biopsy; Bone and Bones; Calcitonin; Dose-Response Relationship, Drug; Etidronic Acid; F | 1974 |
Therapeutic success in Paget disease.
Topics: Administration, Oral; Alkaline Phosphatase; Antineoplastic Agents; Calcitonin; Etidronic Acid; Human | 1973 |